PATENT CLAIM ANALYSIS

Application Number: 16289280
Application Type: Utility
Filing Date: 2019-02
Publication Date: 2019-06
Patent Classification: ["514", "341000"]

Abstract:
The present disclosure discusses salt forms of 4-cyano-N-[2-(4,4-dimethylcyclohex-1-en-1-yl)-6-(2,2,6,6-tetramethyltetrahydro-2H-pyran-4-yl)pyridin-3-yl]-1H-imidazole-2-carboxamide.

Claim (Index 33):
The method of  claim 29 , wherein the pain is selected from skeletal pain caused by tumor metastasis or osteoarthritis, or visceral, inflammatory, or neurogenic pain.

Metadata:
- Claim Count in Document: 71.0
- Percentile: 99.0
- Lexical Diversity: 1.10526
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15651829', '15651385', '14822366', '13801191', '16015626']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.821403435060879
- 35 USC 102 Novelty (BERT): 0.55048163878882
- Combined Prediction Score: 0.7943112554336731
- Mean Citation Score: 343.474226
- Max Citation Score: 427.90027
- Similarity Product: 296.6979730374425

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test